EIP
HELP

Ellis Investment Partners’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Ellis Investment Partners’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-26
Closed – – 309
2022
Q3 		$0 Hold
26
– – ﹤0.01% 800
2022
Q2 		$0 Hold
26
– – ﹤0.01% 789
2022
Q1 		$0 Buy
+26
New +$950 ﹤0.01% 812

Other funds holding HELP

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
IWP
IAG Wealth Partners Waukesha, Wisconsin $1.01B AUM 17.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Ellis Investment Partners's HELP Position: Q4 2022 in Review

Ellis Investment Partners sold out of Helus Pharma Inc. Common Stock (HELP) in Q4 2022, closing a stake of 26 shares.

Ellis Investment Partners first reported a position in HELP in Q1 2022 and held it in 3 quarters. The position peaked at $0 in Q3 2022. 70 funds tracked by Wall St. Rank hold HELP as of Q4 2022.

  • Ellis Investment Partners reported no remaining Helus Pharma Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Ellis Investment Partners sold 26 Helus Pharma Inc. Common Stock shares in Q4 2022.
  • Ellis Investment Partners first reported a position in Helus Pharma Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • Ellis Investment Partners's Helus Pharma Inc. Common Stock position peaked at $0 in Q3 2022.
  • 70 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q4 2022.

Based on Ellis Investment Partners's 13F filing for Q4 2022, filed 31 Jan 2023.